Taking everything into account, GTH scores 2 out of 10 in our fundamental rating. GTH was compared to 533 industry peers in the Biotechnology industry. GTH may be in some trouble as it scores bad on both profitability and health. GTH is valied quite expensively at the moment, while it does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.25% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.92 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.71 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.025
+0.01 (+0.12%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.42 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.69 | ||
| P/tB | 1.79 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.25% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 106.07% | ||
| Cap/Sales | 12.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | -8.92 |
ChartMill assigns a fundamental rating of 2 / 10 to GTH.
ChartMill assigns a valuation rating of 0 / 10 to GENETRON HOLDINGS LTD-ADR (GTH). This can be considered as Overvalued.
GENETRON HOLDINGS LTD-ADR (GTH) has a profitability rating of 1 / 10.
The financial health rating of GENETRON HOLDINGS LTD-ADR (GTH) is 1 / 10.
The Earnings per Share (EPS) of GENETRON HOLDINGS LTD-ADR (GTH) is expected to grow by 20.69% in the next year.